Publication | Closed Access
Non-Randomized Controls in Cancer Clinical Trials
276
Citations
9
References
1974
Year
Cancer RegistrationPharmacotherapyTreatment Plan EvaluationOncologyMetronomic TherapyClinical TrialsRandomized Controlled TrialClinical EfficacyRadiation OncologyCancer ResearchCancer Clinical TrialsHealth SciencesControl GroupClinical Trial ManagementClinical Trial AnalysisClinical StudiesOutcomes ResearchResponse RateComparative Clinical TrialsClinical EffectivenessDrug TrialMedicineClinical Trial EvaluationClinical Trial Design
Abstract Quantitative, comparative clinical trials can sometimes be better accomplished with technics other than randomization for selection of a control group. These include selection of literature controls, matched controls and controls from a previous study. Such controls have permitted detection of therapeutic activity for many anti-cancer agents. Circumstances of greatest utility are as follows: when the primary purpose of study is to estimate effectiveness of treatment; when large differences in response rate are expected on the basis of preliminary studies; or when the new therapy would only be interesting if it was substantially more effective than the standard. When a new therapy is to be evaluated, clinical investigators must consider both ethical responsibility to administer best available therapy and scientific responsibility to conduct a proper evaluation. Selected control patients can permit valid evaluation of a new therapy without the requirement of prescribing control therapy known to be ineffective. (N Engl J Med 290:198–203, 1974)
| Year | Citations | |
|---|---|---|
Page 1
Page 1